Managed Account Advisors’s Charles River Laboratories CRL Stock Holding History

Managed Account Advisors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$9.81M	Buy	139,422 +22,454	+19%	+$1.66M	0.01%	1106
2015 Q1	$9.27M	Buy	116,968 +57,701	+97%	+$4.26M	0.01%	1114
2014 Q4	$3.77M	Buy	59,267 +6,748	+13%	+$423K	﹤0.01%	1521
2014 Q3	$3.14M	Buy	52,519 +25,760	+96%	+$1.47M	﹤0.01%	1605
2014 Q2	$1.43M	Sell	26,759 -7,947	-23%	-$436K	﹤0.01%	1909
2014 Q1	$2.09M	Sell	34,706 -26,018	-43%	-$1.52M	﹤0.01%	1721
2013 Q4	$3.22M	Buy	60,724 +1,638	+3%	+$82.3K	﹤0.01%	1525
2013 Q3	$2.73M	Sell	59,086 -16,525	-22%	-$758K	﹤0.01%	1531
2013 Q2	$3.1M	Buy	+75,611	New	+$3.24M	﹤0.01%	1437

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Managed Account Advisors's CRL Position: Q2 2015 in Review

Managed Account Advisors increased its Charles River Laboratories (CRL) stake by 19% in Q2 2015, buying an estimated $1.66M and bringing the position to 139,422 shares worth $9.81M. The position accounts for 0.01% of the portfolio, ranked #1106.

Managed Account Advisors first reported a position in CRL in Q2 2013 and has held it in 9 quarters since. 261 funds tracked by Wall St. Rank hold CRL as of Q2 2015.

Managed Account Advisors held 139,422 shares of Charles River Laboratories worth $9.81M as of Q2 2015.
Managed Account Advisors bought 22,454 Charles River Laboratories shares in Q2 2015, an estimated $1.66M.
Charles River Laboratories made up 0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1106 holding.
Managed Account Advisors first reported a position in Charles River Laboratories in Q2 2013 and has held it in 9 quarters since.
261 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.